10-Q Filing

ENVERIC BIOSCIENCES, INC. CIK: 890821 Q1 2015

Filing Information

Form Type	10-Q
Accession Number	`0001079974-15-000357`
Period End Date	20150331
Filing Date	20150514
Fiscal Year	2015
Fiscal Period	Q1
XBRL Instance	spzr-20150331.xml

Filing Contents

This filing contains the following financial statements:

Balance Sheet 40 Income Statement 14 Cash Flow Statement 24

Balance Sheet 40 line items

Line Item	Tag	Value	Unit	Period
Preferred stock, par value	`PreferredStockParOrStatedValuePerShare`	$0.01	USD	Point-in-time
Preferred stock, par value	`PreferredStockParOrStatedValuePerShare`	$0.01	USD	Point-in-time
Cash and Cash Equivalents	`CashAndCashEquivalentsAtCarryingValue`	$5.08K	USD	Point-in-time
Cash and Cash Equivalents	`CashAndCashEquivalentsAtCarryingValue`	$22.47K	USD	Point-in-time
Cash and Cash Equivalents	`CashAndCashEquivalentsAtCarryingValue`	$3.90K	USD	Point-in-time
Cash and Cash Equivalents	`CashAndCashEquivalentsAtCarryingValue`	$249.00	USD	Point-in-time
Preferred stock, authorized shares	`PreferredStockSharesAuthorized`	1.00M	shares	Point-in-time
Preferred stock, authorized shares	`PreferredStockSharesAuthorized`	1.00M	shares	Point-in-time
Total Current Assets	`AssetsCurrent`	$5.08K	USD	Point-in-time
Preferred stock, issued shares	`PreferredStockSharesIssued`	0.00	shares	Point-in-time
Total Current Assets	`AssetsCurrent`	$3.90K	USD	Point-in-time
Preferred stock, issued shares	`PreferredStockSharesIssued`	0.00	shares	Point-in-time
Total Assets	`Assets`	$5.08K	USD	Point-in-time
Total Assets	`Assets`	$3.90K	USD	Point-in-time
Preferred stock, outstanding shares	`PreferredStockSharesOutstanding`	0.00	shares	Point-in-time
Preferred stock, outstanding shares	`PreferredStockSharesOutstanding`	0.00	shares	Point-in-time
Common stock, par value	`CommonStockParOrStatedValuePerShare`	$0.01	USD	Point-in-time
Common stock, par value	`CommonStockParOrStatedValuePerShare`	$0.01	USD	Point-in-time
Common stock, authorized shares	`CommonStockSharesAuthorized`	300.00M	shares	Point-in-time
Common stock, authorized shares	`CommonStockSharesAuthorized`	300.00M	shares	Point-in-time
Common stock, issued shares	`CommonStockSharesIssued`	15.41M	shares	Point-in-time
Accounts Payable and Accrued Liabilities	`AccountsPayableAndAccruedLiabilitiesCurrentAndNoncurrent`	$8.96K	USD	Point-in-time
Accounts Payable and Accrued Liabilities	`AccountsPayableAndAccruedLiabilitiesCurrentAndNoncurrent`	$10.34K	USD	Point-in-time
Common stock, issued shares	`CommonStockSharesIssued`	15.41M	shares	Point-in-time
Total Current Liabilities	`LiabilitiesCurrent`	$10.34K	USD	Point-in-time
Common stock, outstanding shares	`CommonStockSharesOutstanding`	15.41M	shares	Point-in-time
Total Current Liabilities	`LiabilitiesCurrent`	$8.96K	USD	Point-in-time
Common stock, outstanding shares	`CommonStockSharesOutstanding`	15.41M	shares	Point-in-time
Preferred shares, $.01 par value, 1,000,000 shares authorized, none issued and outstanding	`PreferredStockValue`	-	USD	Point-in-time
Preferred shares, $.01 par value, 1,000,000 shares authorized, none issued and outstanding	`PreferredStockValue`	-	USD	Point-in-time
Common shares, $.01 par value, 300,000,000 shares authorized, 15,409,999 shares issued and outstanding	`CommonStockValue`	$154.10K	USD	Point-in-time
Common shares, $.01 par value, 300,000,000 shares authorized, 15,409,999 shares issued and outstanding	`CommonStockValue`	$154.10K	USD	Point-in-time
Additional Paid-In Capital	`AdditionalPaidInCapitalCommonStock`	$47.27M	USD	Point-in-time
Additional Paid-In Capital	`AdditionalPaidInCapitalCommonStock`	$47.27M	USD	Point-in-time
Accumulated Deficit	`RetainedEarningsAccumulatedDeficit`	$-47.43M	USD	Point-in-time
Accumulated Deficit	`RetainedEarningsAccumulatedDeficit`	$-47.43M	USD	Point-in-time
Total Stockholders' Deficit	`StockholdersEquity`	$-3.87K	USD	Point-in-time
Total Stockholders' Deficit	`StockholdersEquity`	$-6.45K	USD	Point-in-time
Total Liabilities and Stockholders' Deficit	`LiabilitiesAndStockholdersEquity`	$5.08K	USD	Point-in-time
Total Liabilities and Stockholders' Deficit	`LiabilitiesAndStockholdersEquity`	$3.90K	USD	Point-in-time

Income Statement 14 line items

Line Item	Tag	Value	Unit	Period
General and Administrative	`GeneralAndAdministrativeExpense`	$2.30K	USD	1 Quarter
General and Administrative	`GeneralAndAdministrativeExpense`	$7.58K	USD	1 Quarter
Operating Loss	`OperatingIncomeLoss`	$-2.30K	USD	1 Quarter
Operating Loss	`OperatingIncomeLoss`	$-7.58K	USD	1 Quarter
Loss Before Income Taxes	`IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments`	$-2.30K	USD	1 Quarter
Loss Before Income Taxes	`IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments`	$-7.58K	USD	1 Quarter
Income Taxes	`IncomeTaxExpenseBenefit`	$275.00	USD	1 Quarter
Income Taxes	`IncomeTaxExpenseBenefit`	$283.00	USD	1 Quarter
Net Loss	`NetIncomeLoss`	$-2.58K	USD	1 Quarter
Net Loss	`NetIncomeLoss`	$-7.87K	USD	1 Quarter
Basic and Diluted Loss Per Share	`EarningsPerShareBasicAndDiluted`	-	USD	1 Quarter
Basic and Diluted Loss Per Share	`EarningsPerShareBasicAndDiluted`	-	USD	1 Quarter
Weighted Average Shares Outstanding - Basic and Diluted	`WeightedAverageNumberOfSharesOutstandingBasic`	15.41M	shares	1 Quarter
Weighted Average Shares Outstanding - Basic and Diluted	`WeightedAverageNumberOfSharesOutstandingBasic`	14.90M	shares	1 Quarter

Cash Flow Statement 24 line items

Line Item	Tag	Value	Unit	Period
Net Loss	`NetIncomeLoss`	$-2.58K	USD	1 Quarter
Net Loss	`NetIncomeLoss`	$-7.87K	USD	1 Quarter
Accounts Payable and Accrued Liabilities	`IncreaseDecreaseInAccountsPayableAndAccruedLiabilities`	$1.39K	USD	1 Quarter
Accounts Payable and Accrued Liabilities	`IncreaseDecreaseInAccountsPayableAndAccruedLiabilities`	$-19.91K	USD	1 Quarter
Net Cash Used In Operating Activities	`NetCashProvidedByUsedInOperatingActivities`	$-27.78K	USD	1 Quarter
Net Cash Used In Operating Activities	`NetCashProvidedByUsedInOperatingActivities`	$-1.19K	USD	1 Quarter
Issuance of Common Stock	`ProceedsFromIssuanceOfCommonStock`	-	USD	1 Quarter
Issuance of Common Stock	`ProceedsFromIssuanceOfCommonStock`	$50.00K	USD	1 Quarter
Net Cash Provided by Financing Activities	`NetCashProvidedByUsedInFinancingActivities`	$50.00K	USD	1 Quarter
Net Cash Provided by Financing Activities	`NetCashProvidedByUsedInFinancingActivities`	-	USD	1 Quarter
Increase (decrease) in Cash and Cash Equivalents	`CashAndCashEquivalentsPeriodIncreaseDecrease`	$-1.19K	USD	1 Quarter
Increase (decrease) in Cash and Cash Equivalents	`CashAndCashEquivalentsPeriodIncreaseDecrease`	$22.22K	USD	1 Quarter
Cash and Cash Equivalents, Beginning of Period	`CashAndCashEquivalentsAtCarryingValue`	$5.08K	USD	Point-in-time
Cash and Cash Equivalents, Beginning of Period	`CashAndCashEquivalentsAtCarryingValue`	$22.47K	USD	Point-in-time
Cash and Cash Equivalents, Beginning of Period	`CashAndCashEquivalentsAtCarryingValue`	$3.90K	USD	Point-in-time
Cash and Cash Equivalents, Beginning of Period	`CashAndCashEquivalentsAtCarryingValue`	$249.00	USD	Point-in-time
Cash and Cash Equivalents, End of Period	`CashAndCashEquivalentsAtCarryingValue`	$5.08K	USD	Point-in-time
Cash and Cash Equivalents, End of Period	`CashAndCashEquivalentsAtCarryingValue`	$22.47K	USD	Point-in-time
Cash and Cash Equivalents, End of Period	`CashAndCashEquivalentsAtCarryingValue`	$3.90K	USD	Point-in-time
Cash and Cash Equivalents, End of Period	`CashAndCashEquivalentsAtCarryingValue`	$249.00	USD	Point-in-time
Interest	`InterestPaid`	-	USD	1 Quarter
Interest	`InterestPaid`	-	USD	1 Quarter
Income Taxes	`IncomeTaxesPaid`	$275.00	USD	1 Quarter
Income Taxes	`IncomeTaxesPaid`	$1.73K	USD	1 Quarter

Data is extracted from SEC EDGAR XBRL filings. Values shown are as reported in the filing.